Amphastar Pharmaceuticals, Inc. engages in developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products, and insulin active pharmaceutical ingredient. It operates through Finished Pharmaceutical Products and Active Pharmaceutical Ingredients Products segments. The Finished Pharmaceutical Products segment manufactures, markets, and distributes Primatene Mist, enoxaparin, naloxone, phytonadione, lidocaine, and other critical and non-critical care drugs. The Active Pharmaceutical Ingredients Products segment offers RHI API and porcine insulin API for external customers and internal product development. The company was founded by Zi-Ping Luo and Yong Feng Zhang on February 29, 1996 and is headquartered in Rancho Cucamonga, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
1,615
Frequently Asked Questions
What is market cap of Amphastar Pharmaceuticals Inc?
The market cap of Amphastar Pharmaceuticals Inc is $1.8B
What is the 52 week high for Amphastar Pharmaceuticals Inc?
The 52 week high for Amphastar Pharmaceuticals Inc is $44.46.
What is the 52 week low for Amphastar Pharmaceuticals Inc?
The 52 week low for Amphastar Pharmaceuticals Inc is $26.76.
What is Amphastar Pharmaceuticals Inc stock price today?
Amphastar Pharmaceuticals Inc' stock price today is $37.43.
What is the pe ratio of Amphastar Pharmaceuticals Inc?
The PE ratio of Amphastar Pharmaceuticals Inc is 21.50.
What is the price to book ratio of Amphastar Pharmaceuticals Inc?
The price to book ratio of Amphastar Pharmaceuticals Inc is 3.4219.
What is Amphastar Pharmaceuticals Inc's EBITDA?
Amphastar Pharmaceuticals Inc's EBITDA is 136.238.
What is the 50-day moving average of Amphastar Pharmaceuticals Inc?
The 50-day moving average of Amphastar Pharmaceuticals Inc is 31.8784.
How many employess does Amphastar Pharmaceuticals Inc has?